The group of Zsolt Sebestyen in 2016 found that RhoB modulates the capacity of tumor cells to stimulate Vγ9Vδ2 T cells by coordinating BTN3A1 within the cell membrane [58]. The gene discussed is BTN3A1; the disease is neoplasm.